在 NVI Therapeutics，我們正引領基因編輯的未來革命。
 

獨家的 非病毒性 Direct-Integrate 平台，突破了傳統病毒載體基因插入的限制，實現了技術上的飛躍。此平台靈感來自自然界中逆轉錄病毒整合酶系統的精準特性，能將基因穩定且高效率地整合進宿主基因組中——無需使用病毒顆粒。

透過排除與病毒載體相關的安全風險、製造挑戰與法規複雜性，NVI 的平台為次世代細胞與基因療法提供一個更安全、更簡便、更具成本效益的創新解決方案。

Our proprietary non-viral Direct-Integrate platform represents a transformative leap beyond the limitations of viral-based gene insertion.

Inspired by the natural precision of retroviral integrase systems, our technology enables stable, efficient integration of genes directly into the host genome—without the need for viral particles.

By eliminating the safety risks, manufacturing hurdles, and regulatory complexity tied to viral vectors, NVI’s platform delivers a safer, simpler, and more economical solution for next-generation cell and gene therapies.